NCT06823375 2026-03-04
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Chinese University of Hong Kong
Phase 2 Recruiting
Chinese University of Hong Kong
Tianjin Medical University Cancer Institute and Hospital
Leiden University Medical Center